tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market
RLYB
Rallybio
RESEARCH TOOLSreports

Rallybio (RLYB) Stock Forecast & Price Target

360 Followers
See the Price Targets and Ratings of:

RLYB Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Rallybio
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RLYB Stock 12 Month Forecast

There Are No Analyst Ratings for RLYB In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

RLYB Financial Forecast

RLYB Earnings Forecast

Next quarter’s earnings estimate for RLYB is -$1.20 with a range of -$1.20 to -$1.20. The previous quarter’s EPS was -$1.24. RLYB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year RLYB has Performed in-line its overall industry.
Next quarter’s earnings estimate for RLYB is -$1.20 with a range of -$1.20 to -$1.20. The previous quarter’s EPS was -$1.24. RLYB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year RLYB has Performed in-line its overall industry.

RLYB Sales Forecast

Next quarter’s sales forecast for RLYB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $222.00K. RLYB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year RLYB has Performed in-line its overall industry.
Next quarter’s sales forecast for RLYB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $222.00K. RLYB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year RLYB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI Analyst forecast on RLYB
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
$8
Hold
-12.18%
Downside
Reiterated
12/18/25
Rallybio (RLYB) Gets a Hold from Evercore ISI
TD Cowen Analyst forecast on RLYB
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
11/10/25
Analysts Offer Insights on Healthcare Companies: Rallybio (NASDAQ: RLYB) and Nkarta (NASDAQ: NKTX)
Citizens JMP Analyst forecast on RLYB
Jonathan Wolleben
Citizens JMP
Citizens JMP
―
Hold
―
Reiterated
04/23/25
Citizens JMP reiterates Market Perform Rating on Rallybio Corp. (RLYB)Citizens JMP analyst Jonathan Wolleben reiterated a Market Perform rating on Rallybio Corp. (NASDAQ: RLYB).
JonesTrading Analyst forecast on RLYB
Catherine Novack
JonesTrading
JonesTrading
―
Hold
―
Downgraded
04/14/25
Rallybio downgraded to Hold from Buy at JonesResearchRallybio downgraded to Hold from Buy at JonesResearch
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Evercore ISI Analyst forecast on RLYB
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
$8
Hold
-12.18%
Downside
Reiterated
12/18/25
Rallybio (RLYB) Gets a Hold from Evercore ISI
TD Cowen Analyst forecast on RLYB
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
11/10/25
Analysts Offer Insights on Healthcare Companies: Rallybio (NASDAQ: RLYB) and Nkarta (NASDAQ: NKTX)
Citizens JMP Analyst forecast on RLYB
Jonathan Wolleben
Citizens JMP
Citizens JMP
―
Hold
―
Reiterated
04/23/25
Citizens JMP reiterates Market Perform Rating on Rallybio Corp. (RLYB)Citizens JMP analyst Jonathan Wolleben reiterated a Market Perform rating on Rallybio Corp. (NASDAQ: RLYB).
JonesTrading Analyst forecast on RLYB
Catherine Novack
JonesTrading
JonesTrading
―
Hold
―
Downgraded
04/14/25
Rallybio downgraded to Hold from Buy at JonesResearchRallybio downgraded to Hold from Buy at JonesResearch
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Rallybio

3 Months
xxx
Success Rate
2/14 ratings generated profit
14%
Average Return
-22.40%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 14.29% of your transactions generating a profit, with an average return of -22.40% per trade.
1 Year
Ritu BaralTD Cowen
Success Rate
3/14 ratings generated profit
21%
Average Return
-21.01%
Copying Ritu Baral's trades and holding each position for 1 Year would result in 21.43% of your transactions generating a profit, with an average return of -21.01% per trade.
2 Years
xxx
Success Rate
7/14 ratings generated profit
50%
Average Return
+0.66%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.66% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RLYB Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
1
1
0
0
0
Hold
2
1
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
2
1
0
0
In the current month, RLYB has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RLYB average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

RLYB Stock Forecast FAQ

What is RLYB’s average 12-month price target, according to analysts?
Currently, no data Available
What is RLYB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RLYB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is RLYB a Buy, Sell or Hold?
      Currently, no data Available
      What is Rallybio’s price target?
      Currently, no data Available
      What do analysts say about Rallybio?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of RLYB?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.